Scolaris Content Display Scolaris Content Display

Cyclobenzaprine for the treatment of myofascial pain in temporomandibular disorders

This is not the most recent version

References

Additional references

Al‐Ani 2005

Al‐Ani Z, Gray RJ, Davies SJ, Sloan P, Glenny AM. Stabilization splint therapy for the treatment of temporomandibular myofascial pain: a systematic review. Journal of Dental Education 2005;69(11):1242‐50. [MEDLINE: 16275687]

De Lucena 2006

De Lucena LB, Kosminsky M, da Costa LJ, de Goes PS. Validation of the Portuguese version of the RDC/TMD Axis II questionnaire. Pesquisa Odontológica Brasileira ‐ Brazilian Oral Research 2006;20(4):312‐7. [MEDLINE: 17242791]

DerSimonian 1986

DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;4(3):177‐88.

Dworkin 1992

Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. Journal of Craniomandibular Disorders: Facial & Oral Pain 1992;6(4):301‐55. [MEDLINE: 1298767]

Fricton 1989

Fricton JR, Schiffman EL. Research in temporomandibular disorders. Northwest Dentistry 1989;68(4):29‐30. [MEDLINE: 2637428]

Higgins 2003

Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analysis. BMJ 2003;327:555‐7.

Higgins 2006

Higgins JPT, Green S, editors. Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; section 6. The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd, 2007.

Jüni 1999

Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta‐analysis. The Journal of the American Medical Association 1999;282(11):1054‐60.

Kobayashi 1996

Kobayashi H, Hasegawa Y, Ono H. Cyclobenzaprine, a centrally acting muscle relaxant, acts on descending serotonergic systems. European Journal of Pharmacology 1996;311(1):29‐35.

Koh 2003

Koh H, Robinson PG. Occlusal adjustment for treating and preventing temporomandibular joint disorders. Cochrane Database of Systematic Reviews 2003, Issue 1. [MEDLINE: 12535488]

Lance 1964

Lance JW, Curran DA. Treatment of chronic tension headache. Lancet 1964;42:1236‐9. [MEDLINE: 14152626]

Lance 1972

Lance JW, Anthony M. Cyclobenzaprine in the treatment of chronic tension headache. The Medical Journal of Australia 1972;2(25):1409‐11. [MEDLINE: 5819771]

Laskin 1969

Laskin DM. Etiology of the pain‐dysfunction syndrome. Journal of the American Dental Association 1969;79(1):147‐53. [MEDLINE: 5254545]

List 1996

List T, Dworkin SF. Comparing TMD diagnoses and clinical findings at Swedish and US TMD centers using research diagnostic criteria for temporomandibular disorders. Journal of Orofacial Pain 1996;10(3):240‐53. [MEDLINE: 9161229]

List 1999

List T, Wahlund K, Wenneberg B, Dworkin SF. TMD in children and adolescents: prevalence of pain, gender differences, and perceived treatment need. Journal of Orofacial Pain 1999;13(1):9‐20. [MEDLINE: 10425964]

Manfredini 2006

Manfredini D, Chiappe G, Bosco M. Research diagnostic criteria for temporomandibular disorders (RDC/TMD) axis I diagnoses in an Italian patient population. Journal of Oral Rehabilitation 2006;33(8):551‐8. [MEDLINE: 16856952]

McMillan 1997

McMillan AS, Nolan A, Kelly PJ. The efficacy of dry needling and procaine in the treatment of myofascial pain in the jaw muscles. Journal of Orofacial Pain 1997;11(4):307‐14. [MEDLINE: 9656906]

Okeson 1998

Okeson JP. Orofacial Pain: Guidelines for assessment, Diagnosis and Management. Quintessence Publishing Co Inc, 1998.

Okeson 2006

Okeson JP. Bell's Orofacial Pain. 6. São Paulo: Quintessence publishing Co, Inc, 2006.

Pertes 2005

Pertes RA, Gross SG. Clinical Management Of Temporomandibular Disorders and Orofacial Pain. Quintessence Publishing Co. Inc., 2005.

Shi 2003

Shi Z, Guo C, Awad M. Hyaluronate for temporomandibular joint disorders. Cochrane Database of Systematic Reviews 2003, Issue 1. [MEDLINE: 12535445]

Simons 2005

Simons DG, Travell JG, Simons LS. Travell & Simons Myofascial Pain and Dysfunction: The Trigger Point Manual. 2. Vol. 1, Sao Paulo: ArtMed, 2005.

Solberg 1986

Solberg WK. Temporomandibular disorders: masticatory myalgia and its management. British Dental Journal 1986;160(10):351‐6. [MEDLINE: 3459485]

Sterne 2001

Sterne JAC, Egger M, Davey Smith G. Investigating and dealing with publication and other biases. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care; Meta‐analysis in Context. London: BMJ Publishing Group, 2001:189‐208.

Tang 2000

Tang JL, Liu JLY. Misleading funnel plot for detection of bias in meta‐analysis. Journal of Clinical Epidemiology 2000;53:477‐84.

Thornton 2000

Thornton A, Lee P. Publication bias in meta‐analysis: its causes and consequences. Journal of Clinical Epidemiology 2000;53(2):207‐16. [MEDLINE: 10729693]

Travell 1952

Travell J, Rinzler SH. The myofascial genesis of pain. Postgraduate Medicine 1952;11(5):425‐34. [MEDLINE: 15509460]

Unnebrink 2001

Unnebrink K, Windeler J. Intention‐to‐treat methods for dealing with missing values in clinical trials of progressively deteriorating diseases. Statistics in Medicine 2001;20(24):3931‐46.

Yap 2003

Yap AU, Dworkin SF, Chua EK, List T, Tan KB, Tan HH. Prevalence of temporomandibular disorder subtypes, psychologic distress, and psychosocial dysfunction in Asian patients. Journal of Orofacial Pain 2003;17(1):21‐8. [MEDLINE: 12756927]
Table 1. Search strategy ‐ types of studies

PUBMED

EMBASE

LILACS

CENTRAL

#1 MYOFASCIAL PAIN SYNDROMES [MeSH]
#2 TEMPOROMANDIBULAR JOINT DISORDERS [MeSH]
#3 ("myofascial pain" OR (jaw* AND pain*))
#4 ((Temporomandibular joint* or "temporo‐mandibular joint*" or "TMJ") AND pain*)
#5 (myofascial AND ("trigger point" or trigger‐point*))
#6 #1 or #2 or #3 or #4 or #5
#7 (cyclobenzaprine OR "cyclobenzaprine hydrochloride" OR Aripiprazole OR "Dorixina relax" OR Flexeril OR Lisseril OR Miosan OR Mirtax OR Fexmid OR Flexeril OR Flexiban OR Flexitec OR Gen‐Cyclobenzaprine OR Masterelax OR Medarex OR Med Cyclobenzaprine OR Miosan OR Mirtax OR Nostaden OR Novo‐Cycloprine OR Amrix OR Apo‐Cyclobenzaprine OR Ciclamil OR Ratio‐Cyclobenzaprine OR Reflexan OR Relexil OR Riva‐Cycloprine OR Tensamon OR Tensamox OR Tensiomax OR Tensodox OR Tonalgen OR Yuredol OR Yurelax OR Ziclob))
#8 #6 AND #7

1. MYOFASCIAL PAIN SYNDROME [EMTREE term]
2. TEMPOROMANDIBULAR JOINT DISORDER [EMTREE term]
3. ("myofascial pain" or (jaw$ adj5 pain$))
4. ((Temporomandibular joint$ or "temporo‐mandibular joint$" or "TMJ") AND pain$)
5. (myofascial AND ("trigger point$" or trigger‐point$))
6.OR/1‐5
7. (cyclobenzaprine OR "cyclobenzaprine hydrochloride" OR Aripiprazole OR "Dorixina relax" OR Flexeril OR Lisseril OR Dibenzocycloheptenes OR Miosan OR Mirtax OR Fexmid OR Flexeril OR Flexiban OR Flexitec OR Gen‐Cyclobenzaprine OR Masterelax OR Medarex OR Med Cyclobenzaprine OR Miosan OR Mirtax OR Nostaden OR Novo‐Cycloprine OR Amrix OR Apo‐Cyclobenzaprine OR Ciclamil OR Ratio‐Cyclobenzaprine OR Reflexan OR Relexil OR Riva‐Cycloprine OR Tensamon OR Tensamox OR Tensiomax OR Tensodox OR Tonalgen OR Yuredol OR Yurelax OR Ziclob)
8. 6 AND 7

(Mh random allocation) OR (Mh double blind method) OR (Mh single blind method) AND NOT (Ct animal) AND NOT (Ct human and Ct animal) OR (Pt clinical trial) OR (Ex E05.318.760.535$) OR (Tw clin$) AND (Tw trial$) OR (Tw ensa$) OR (Tw estud$) OR (Tw experim$) OR (Tw investiga$) OR (Tw singl$) OR (Tw simple$) OR (Tw doubl$) OR (Tw doble$) OR (Tw duplo$) OR (Tw trebl$) OR (Tw trip$) AND (Tw blind$) OR (Tw cego$) OR (Tw ciego$) OR (Tw mask$) OR (Tw mascar$) OR (Mh placebos) OR (Tw placebo$) OR (Tw random$) OR (Tw randon$) OR (Tw casual$) OR (Tw acaso$) OR (Tw azar) OR (Tw aleator$) OR (Mh research design) AND NOT (Ct animal) AND NOT (Ct human and Ct animal) OR (Ct comparative study) OR (Ex E05.337$) OR (Mh follow‐up studies) OR (Mh prospective studies) OR (Tw control$) OR (Tw prospectiv$) OR (Tw volunt$) OR (Tw volunteer$) AND NOT ((Ct animal) AND NOT (Ct human and Ct animal))

# Exp MYOFASCIAL PAIN SYNDROMES
#2 ("myofascial pain" OR (jaw* NEAR pain*))
#3 ((Temporomandibular joint* or "temporo‐mandibular joint*" or "TMJ") AND pain*)
#4 (myofascial AND ("trigger point" or trigger‐point*))
#5 Exp TEMPOROMANDIBULAR JOINT DISORDERS
#6 #1 or #2 or #3 or #4 or #5
#7 (cyclobenzaprine OR "cyclobenzaprine hydrochloride" OR Aripiprazole OR "Dorixina relax" OR Flexeril OR Lisseril OR Dibenzocycloheptenes OR Miosan OR Mirtax OR Fexmid OR Flexeril OR Flexiban OR Flexitec OR Gen‐Cyclobenzaprine OR Masterelax OR Medarex OR Med Cyclobenzaprine OR Miosan OR Mirtax OR Nostaden OR Novo‐Cycloprine OR Amrix OR Apo‐Cyclobenzaprine OR Ciclamil OR Ratio‐Cyclobenzaprine OR Reflexan OR Relexil OR Riva‐Cycloprine OR Tensamon OR Tensamox OR Tensiomax OR Tensodox OR Tonalgen OR Yuredol OR Yurelax OR Ziclob)
#8 #6 AND #7

Figures and Tables -
Table 1. Search strategy ‐ types of studies